Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

November 6, 2023

Optical coherence tomography (OCT) measurements and disability in multiple sclerosis (MS): A systematic review and meta-analysis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis (MS) Symptoms
    /
 Omid Mirmosayyeb 1, Mohammad Yazdan Panah 2, Yousef Mokary 2, Elham Moases Ghaffary 2, Hamed Ghoshouni 2, Robert Zivadinov 3,…
MS Research Study and Reports

November 6, 2023

A mixed-methods feasibility case series of a job retention vocational rehabilitation intervention for people with multiple sclerosis

  • MS Research Study and Reports
    /
Purpose To ascertain the feasibility and acceptability of delivering a job retention vocational rehabilitation intervention [MSVR] for people with multiple…
MS Research Study and Reports

November 1, 2023

Is Multiple Sclerosis Hereditary?

  • Caregiver related
    /
  • MS Research Study and Reports
    /
  If you have multiple sclerosis — an autoimmune disease that attacks nerves in the spinal cord and brain —…
Caregiver related

October 28, 2023

Autonomic Symptom Burden and Decreased Quality of Life Among Patients With MS and NMOSD

  • Multiple Sclerosis
    /
  • NMO (NMOSD/Devics)
    /
  Researchers in Serbia identified link between autonomic symptom burden and quality of life. Recently published findings in the journal Multiple…
Multiple Sclerosis

October 28, 2023

AI Algorithm May Predict Medication Adherence in Patients with MS

  • Misc. Research Reports
    /
 September 22, 2023 Rosanna Sutherby, Pharm.D. woop, a New York-based company, has launched an algorithm that may help people with…
Misc. Research Reports

October 28, 2023

New Data Shows Positive Efficacy and Safety Outcomes After 10 Years of Ocrevus Treatment

  • MS Drug Therapies
    /
  • Ocrevus
    /
 October 18, 2023 Rosanna Sutherby, Pharm.D. In 2017, the FDA approved Genentech’s Ocrevus (ocrelizumab) for the treatment of relapsing forms…
MS Drug Therapies

October 28, 2023

Intranasal Foralumab for Multiple Sclerosis Now Approved by FDA for At-Home Dosing

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
 October 20, 2023 Isabella Ciccone, M.P.H. The FDA’s decision to allow at-home dosing of intransal foralumab for patients with multiple…
MS Drug Therapies

October 28, 2023

PML, a Rare Side Effect of Tysabri, Found to Worsen Long-Term Disability in Patients with MS

  • Multiple Sclerosis
    /
  • Tysabri
    /
 October 11, 2023 Rosanna Sutherby, Pharm.D. Progressive multifocal leukoencephalopathy (PML) is caused by John Cunningham virus (JCV). A recently published…
Multiple Sclerosis

October 23, 2023

Neurofilament Light Predicts MS Worsening in Silent Progression

  • MS BIOMARKERS
    /
  NfL changes occurred in advance of, not coincident with, clinical worsening by Judy George, Deputy Managing Editor, MedPage Today October 17,…
MS BIOMARKERS

October 23, 2023

S1P Receptor Modulator May Boost Cognitive Processing Speed in Early MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis (MS) Symptoms
    /
Ozanimod (Zeposia) led to test score improvements in interim analysis by Judy George, Deputy Managing Editor, MedPage Today October 19, 2023 Share…
MS Drug Therapies

Categories

Latest Blog Posts